$PRSU

Pursuit (PRSU) Q2 2026 Earnings Call Transcript

Pursuit (PRSU) discussed its Q2 2026 earnings call, saying it completed the sale of its noncore Flyover business to Klook, strengthening its balance sheet. The company raised full-year 2026 guidance and expects 14% adjusted EBITDA growth at the midpoint. It reported pro forma June 30 net leverage of about 1x and $220 million liquidity, and cited Vision 2030 targets of over $265 million adjusted EBITDA by 2030.

Original reporting
Published Aug 14, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 12:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Pursuit (PRSU) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PRSUBullishMed
01

Why it matters

The call excerpt highlights portfolio simplification, higher 2026 guidance, and pro forma leverage/liquidity, which together can change near-term valuation expectations and risk perception.

02

Market read

Traders can update PRSU models based on raised full-year 2026 guidance, a stated adjusted EBITDA growth target, and pro forma leverage/liquidity after the Flyover sale.

03

What to watch

The excerpt does not provide segment-level margins, transaction accounting details, or how Flyover sale proceeds translate into specific capex or acquisition timing, which could affect how sustainable the EBITDA growth is.

Relevance 8/10Novelty 7/10Timing: during/after the Q2 2026 earnings call today

Background

Pursuit (PRSU) is positioning itself as a pure-play attractions and hospitality operator after completing the sale of its noncore Flyover business.

Company-level read

Ticker impact

$PRSUBullishMedium confidence
Context

Pursuit says it completed the sale of its noncore Flyover business and increased full-year 2026 guidance, targeting 14% adjusted EBITDA growth at the midpoint.

Expected impact

Moderately positive bias for PRSU as guidance is raised and leverage is described as ~1x pro forma with $220M liquidity.

Evidence & confidence

The transcript includes concrete, decision-relevant disclosures: sale completion, guidance increase, adjusted EBITDA growth target, and pro forma leverage/liquidity. However, it is an earnings call transcript, and the excerpt does not include full financial tables or consensus context.

Market effects

Supports the view that experiential attractions operators can monetize noncore assets to fund growth and margin expansion.

No specific regional demand shock is disclosed; commentary is destination-anchored and global.

Travel-experience demand framing is broad, but the actionable items are company-specific (divestiture and guidance).

Counterpoint

Guidance increase may be partially driven by incremental contributions from a transaction, so underlying organic demand and margins may be less improved than headline numbers suggest.

Key entities

  • Pursuit

    Company conducting the Q2 2026 earnings call and providing updated 2026 guidance and balance-sheet metrics.

  • Flyover

    Noncore flyover business Pursuit says it has sold, with proceeds supporting balance-sheet strength.

  • Klook

    Named as the new owner of Flyover in the transcript.

  • Eagle Wing tours

    Named as the strategic transaction whose incremental contributions are included in the increased 2026 guidance.

Related articles

$PRSUHigh

Pursuit Attractions & Hospitality, Inc. (PRSU): Results of Operations and Financial Condition

Pursuit Attractions & Hospitality, Inc. (PRSU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prsu-ex99_1.htm EX-99.1 EX-99.1 NEWS FOR IMMEDIATE RELEASE Exhibit 99.1 PURSUIT Reports Record SECOND quarter 2026 Results and UPDATES full year guidance WHILE ADVANCING LONG-TERM GROWTH INITIATIVES DENVER, August 5, 2026 -- Pursuit Attractions and Hospitality, Inc. (“P

$PRHIMed

Presurance Holdings, Inc. (PRHI): Results of Operations and Financial Condition

Presurance Holdings, Inc. (PRHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prhi-ex99_1.htm EX-99.1 EX-99.1 News Release For Further Information: Jessica Gulis, 248.509.9202 ir@prehld.com Presurance Holdings Reports 2026 Second Quarter Financial Results Troy, MI, August 12, 2026 – Presurance Holdings, Inc. (Nasdaq: PRHI) (“Presurance” or the “C

$BRUNMed

Boost Run Inc. (BRUN): Results of Operations and Financial Condition

Boost Run Inc. (BRUN) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0002090646 0002090646 2026-08-14 2026-08-14 0002090646 BRUN:ClassCommonStock0.0001ParValueMember 2026-08-14 2026-08-14 0002090646 BRUN:WarrantsEachWholeWarrantIsExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2026-08-14 2026-08-14 iso4217:USD xb

$OMERMed

Omeros Corporation Q2 2026 Earnings Call Summary

Omeros reported Q2 2026 progress for Yartemlia, citing 188% quarter-over-quarter net sales growth and $4.1 million positive operating cash flow. Management said adult transplant centers now drive about 75% of sales and formulary approval is 55% to 60%. It also discussed cash flow positivity by mid-2027, repurchases, and regulatory items including a July 1 J-code and Oct. 1 NTAP.

$AMATMed

Applied Materials shares are down on elevated expectations. Here's why analysts say it's time to buy.

Applied Materials (AMAT) shares fell more than 5% in premarket after it reported results Thursday. The company posted revenue of $9.1B, up 25% year over year and above FactSet’s $8.99B consensus, and EPS of $3.50 vs $3.40. Guidance and gross-margin pressure from higher capex were cited. JPMorgan raised its price target to $660; KeyBanc and Jefferies also reiterated targets.

Med

MaxCyte, Inc. Q2 2026 Earnings Call Summary

MaxCyte reported Q2 2026 sequential revenue growth after inventory drawdowns from a major customer and clinical program discontinuations. It signed a multi-platform enterprise partnership with Genentech and expects 2026 revenue guidance of $30m to $32m. Operating expenses fell 25% YoY. Company plans to use most of a $10m share repurchase program and expects mid-70s gross margins.